7.84 USD
▼-0.14-1.75%
盘后 10.01 0.00%
2026-11-20
市值
$222.19M
市盈率
—
EPS
-2.35
股息率
—
52 周区间
7.84 – 17.15
成交量
33.77K
Beta
0.76
目标价
21.50
52W 低 7.8452W 高 17.15
价格走势
公司简介
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for virology and immunology indications. The company’s product pipeline comprises EDP-514, which is in phase 1b clinical development for the treatment of chronic infection with hepatitis B virus or HBV; zelicapavir and EDP-323, which is in phase II clinical development for the treatment of respiratory syncytial virus; EDP-235, which is in phase II clinical development for the treatment of human coronaviruses; EDP-978 for chronic spontaneous urtica...